Terns Pharmaceuticals
TERN
TERN
42 hedge funds and large institutions have $26.4M invested in Terns Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
47% less capital invested
Capital invested by funds: $50M → $26.4M (-$23.6M)
Holders
42
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.13M | |
| 2 | +$1.74M | |
| 3 | +$995K | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$936K |
| 5 |
Millennium Management
New York
|
+$469K |
Top Sellers
| 1 | -$6.97M | |
| 2 | -$5.5M | |
| 3 | -$1.46M | |
| 4 |
AC
Antara Capital
New York
|
-$497K |
| 5 |
State Street
Boston,
Massachusetts
|
-$354K |